27. Spector, T.D., BMJ (5 May 1990); 300 (6733): 1173–4. Trends in admissions for hip fracture in England and Wales, 1968–85.
28. Hall, K.D., Lancet (27 Aug 2011); 378 (9793): 826–37. Quantification of the effect of energy imbalance on bodyweight.
29. Williams, P.T., Int J Obes (Mar 2006); 30 (3): 543–51. The effects of changing exercise levels on weight and age-related weight gain.
30. Hall, K.D., Lancet (27 Aug 2011); 378 (9793): 826–37. Quantification of the effect of energy imbalance on bodyweight.
31. Turner, J.E., Am J Clin Nutr (Nov 2010); 92 (5): 1009–16. Nonprescribed physical activity energy expenditure is maintained with structured exercise and implicates a compensatory increase in energy intake.
32. Strasser, B., Ann NY Acad Sci (Apr 2013); 1281: 141–59. Physical activity in obesity and metabolic syndrome.
33. Dombrowski, S.U., BMJ (14 May 2014); 348: g2646. Long-term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials.
34. Ekelund, U., Am J Clin Nutr (14 Jan 2015). Activity and all-cause mortality across levels of overall and abdominal adiposity in European men and women: the European Prospective Investigation into Cancer and Nutrition Study.
35. Hainer, V., Diabetes Care (Nov 2009); 32 Suppl 2: S392. Fat or fit: what is more important?
36. Fogelholm, M., Obes Rev (Mar 2010); 11 (3): 202–21. Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors.
37. Viloria, M., Immunol Invest (2011); 40: 640–56. Effect of moderate exercise on IgA levels and lymphocyte count in mouse intestine.
38. Matsumoto, M., Biosci, Biotechnol Biochem (2008); 72: 572–6. Voluntary running exercise alters microbiota composition and increases n-butyrate concentration in the rat cecum.
39. Hsu, Y.J., J Strength Cond Res (20 Aug 2014). Effect of intestinal microbiota on exercise performance in mice.
40. Clarke, S.F., Gut (Dec 2014); 63 (12): 1913–20. Exercise and associated dietary extremes impact on gut microbial diversity.
41. Kubera, B., Front Neuroenergetics (8 Mar 2012); 4: 4. The brain’s supply and demand in obesity.
3. Жиры, итого
1. de Nijs, T., Crit Rev Clin Lab Sci (Nov 2013); 50 (6): 163–71. ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.
2. Kaur, N., J Food Sci Technol (Oct 2014); 51 (10): 2289–303. Essential fatty acids as functional components of foods, a review.
3. Chowdhury, R., Ann Intern Med (18 Mar 2014); 160 (6): 398–406. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
4. Würtz, P., Circulation (8 Jan 2015). pii: 114.013116. Metabolite profiling and cardiovascular event risk: a prospective study of three population-based cohorts.
5. Albert, B.B., Sci Rep (21 Jan 2015); 5: 7928. doi: 10.1038/srep07928. Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA.
6. Ackman, R.G., J Am Oil Chem Soc (1989); 66: 1162–64. EPA and DHA contents of encapsulated fish oil products.
7. Opperman, M., Cardiovasc J Afr (2011); 22: 324–29. Analysis of omega-3 fatty acid content of South African fish oil supplements.
8. Micha, R., BMJ (2014); 348: g2272. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys.
9. Campbell, T.C., Am J Cardiol (26 Nov 1998); 82 (10B): 18T–21T. Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study.
10. Campbell, T.C., The China Study (BenBella Books, 2006).
4. Жиры насыщенные
1. Law, M., BMJ (1999); 318: 1471–80. Why heart disease mortality is low in France: the time lag explanation.
2. Bertrand, X., J Appl Microbiol (Apr 2007); 102 (4): 1052–9. Effect of cheese consumption on emergence of antimicrobial resistance in the intestinal microflora induced by a short course of amoxicillin-clavulanic acid.
3. https://www.youtube.com/watch?v=134aMOQwyhY.
4. David, L.A., Nature (23 Jan 2014); 505 (7484): 559–63.
5. Teicholz, N., The Big Fat Surprise (Simon & Schuster, 2014)
6. Goldacre, B., BMJ (2014); 349 doi: http://dx.doi.org/10.1136/bmj.g4745. Mass treatment with statins.
7. Harborne, Z., Open Heart (2015); 2: doi: 10.1136/openhrt-2014-000196. Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis.
8. Siri-Tarino, P.W., Am J Clin Nutr (2010); 91: 535–46. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.
9. Hjerpsted, J., Am J Clin Nutr (2011); 94: 1479–84. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content.
10. Rice, B.H., Curr Nutr Rep (15 Mar 2014); 3: 130–38. Dairy and Cardiovascular Disease: A Review of Recent Observational Research.
11. Tachmazidou, I., Nature Commun (2013); 4: 2872. A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates.
12. Minger, D., Death by Food Pyramid (Primal Blueprint, 2013).
13. Chen, M., Am J Clin Nutr (Oct 2012); 96 (4): 735–47. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials.
14. Martinez-Gonzalez, M., Nutr Metab Cardiovasc Dis (Nov 2014); 24 (11): 1189–96. Yogurt consumption, weight change and risk of overweight/obesity: the SUN cohort.
15. Jacques, P., Am J Clin Nutr (May 2014); 99 (5): 1229S–34S. Yogurt and weight management.
16. Kano, H., J Dairy Sci (2013); 96: 3525–34. Oral administration of Lactobacillus delbrueckii subspecies bulgaricus OLL1073R-1 suppresses inflammation by decreasing interleukin-6 responses in a murine model of atopic dermatitis.
